We recently created a new model of murine obesity through transgenic a
blation of brown adipose tissue (BAT) using a tissue-specific toxigene
(6), The goal of the present study was to further define the altered
glucose homeostasis and insulin resistance in these transgenic animals
, Despite an similar to 30% increase in total body lipid, no abnormali
ties were observed in 6-week-old transgenic animals, At the age of 22-
26 weeks, marked obesity in transgenic mice was associated with signif
icant increases in blood glucose and plasma insulin levels and an abno
rmal response to both intraperitoneal glucose and insulin tolerance te
sts, Glucose transport in soleus muscle was reduced, with the response
to insulin stimulation blunted by up to 85% in males and 55% in femal
es. The total number of insulin receptors was decreased by 36% in musc
le and 59% in adipose tissue of transgenic animals, Insulin receptor t
yrosine kinase activity, which was assessed following maximal insulin
stimulation in vivo, was reduced in transgenic animals by 59% in muscl
e and 56% in fat, GLUT4 mRNA and protein was unchanged in muscle of tr
ansgenic animals compared with in that of controls but was significant
ly reduced in adipose tissue, In conclusion, primary BAT deficiency re
sults in the development of glucose intolerance or diabetes and severe
insulin resistance with both receptor and postreceptor components. Th
ese animals should be a useful model for studies of obesity-linked dia
betes and insulin resistance and related complications,